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Obstructive sleep apnea (OSA) is a sleep-related breathing disorder characterized by repet-
itive episodes of airﬂow cessation resulting in brief arousals and intermittent hypoxemia.
Several studies have documented signiﬁcant daytime cognitive and behavioral dysfunction
that seems to extend beyond that associated with simple sleepiness and that persists in
some patients after therapeutic intervention. A still unanswered question is whether cogni-
tive symptoms in OSA are primarily a consequence of sleep fragmentation and hypoxemia,
or whether they coexist independently from OSA. Moreover, very little is known about OSA
effects on cognitive performances in the elderly in whom an increased prevalence of OSA
is present. In this review we will consider recent reports in the association between sleep
apnea and cognition, with speciﬁc interest in elderly subjects, in whom sleep disturbances
and age-related cognitive decline naturally occur. This will allow us to elucidate the behav-
ioral and cognitive functions in OSA patients and to gain insight into age differences in
the cognitive impairment. Clinically, these outcomes will aid clinicians in the evaluation of
diurnal consequences of OSA and the need to propose early treatment.
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INTRODUCTION
Previous studies investigating the effects of obstructive sleep apnea
(OSA) on alertness and cognitive functions have demonstrated
that apnea recurrence, sleep fragmentation, and nocturnal hypox-
emia may affect diurnal behavior, cognitive function, and well-
being in these patients. A wide range of cognitive impairment
has been identiﬁed in OSA patients, from attention and vigilance
to memory and executive functions (Jackson et al., 2011). A still
controversial point is which factor is mainly responsible for the
cognitive impairment, given that up to now all considered fac-
tors, i.e., sleep fragmentation, sleepiness, apnea+ hypopnea index
(AHI), and hypoxemia, showed weak correlation with cognitive
scores. Moreover, standard measures used in the clinical setting do
not provide a reliable assessment of cognitive dysfunction, partic-
ularly in elderly subjects in whom it is difﬁcult to differentiate
between the age-related cognitive decline and the OSA-related
impairment.
In this review, current knowledge about the type of cognitive
dysfunction and the mechanisms underlying cognitive impair-
ment are reviewed. Then we summarize what is know about
cognitive dysfunction in the elderly inwhomconﬂicting results are
reported in the literature. These controversial data open discussion
on the effect of therapy on cognitive dysfunction.
INCIDENCE OF SLEEP APNEA SYNDROME
Previous studies on sleep-related breathing disorders have focused
on OSA to indicate a clinical entity characterized by repetitive
episodes of complete or partial upper airway obstruction dur-
ing sleep, inducing falls in oxygen saturation, and hypercapnia.
To restore pharyngeal patency, patients have recurrent arousals
from sleep, inducing sleep fragmentation and sleep discontinuity.
The nocturnal hypoxemia and the recurrent arousals contribute
to the development of sleepiness, hypertension, and cognitive
impairment. Several factors increase the OSA risk such as genetic
predisposition, obesity, upper airways shape (Pillar et al., 2000),
craniofacial morphology (Schellenberg et al., 2000), hormonal
inﬂuences (Bixler et al., 2001), and APOE4 phenotype. (Gottlieb
et al., 2004)
Prevalence studies conducted over the past decades (Young
et al., 1993; Quan et al., 1997; Bixler et al., 2001) have demon-
strated that up to 5% of adults in Western countries are likely
to have undiagnosed OSA. When we consider the severity of the
disease stratiﬁed according to an AHI≥ 5 and an AHI≥ 15, the
prevalence is from 3 to 28% for mildly severe cases (AHI> 5) and
from 1 to 14% for moderately severe cases (AHI> 15). Results of
cohorts in Wisconsin (1490 subjects; Young et al., 1993), Pennsyl-
vania (932 subjects; Bixler et al., 1998, 2001), Spain (455 subjects;
Duran et al., 2001), and from the Sleep Heart Health Study (6642
subjects; Quan et al., 1997) have demonstrated that 1 in every
ﬁve adults has at least an AHI> 5 and 1 in every 15 has at
least an AHI> 15. In community-dwelling older adults (age 65–
95 years), 81% of participants had an AHI> 5, with prevalence
rates of 62% for an AHI> 10, 44% for an AHI> 20, and 24% for
an AHI> 40 (Ancoli-Israel et al., 1991). Furthermore, in about
6000 older adults aged 63.5 years examined in the Sleep Heart
Health study (Young et al., 2002) the authors found that in sub-
jects aged 60–69 years, 32% had an AHI between 5 and 14, and
19% an AHI> 15. The rising trend in elderly subjects may be
explained by changes in the anatomy or function of the upper air-
way (Eikermann et al., 2007) or by the coexistence of othermedical
disorders, i.e., diabetes, hypertension, and cardiovascular disease.
However, recent data suggest that in the elderly, the cut-off point
of an AHI of 5 or 10 (Ancoli-Israel and Coy, 1994) is a less sen-
sitive marker in distinguishing subjects with or without OSA, an
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AHI≤ 15 being present in the majority of healthy elderly subjects
(Pavlova et al., 2008). This would support the hypothesis (Bliwise,
1994; Bixler et al., 1998; Pavlova et al., 2008; Lavie and Lavie, 2009)
that the presence of a greater AHI in the older population may
reﬂect either an age-related or an age-dependent disease, the ﬁrst
inducing the typical OSA symptoms, and the second having fewer
clinical consequences.
COGNITIVE PERFORMANCE AND OSA
Despite differences in the deﬁnition of OSA syndrome, several
studies suggest that apnea recurrence, sleep fragmentation, day-
time sleepiness, and nocturnal hypoxemiamay induce an impaired
cognitive function in OSA patients (Kim et al., 1997; Engleman
and Joffe, 1999; Engleman et al., 2000; Adams et al., 2001) affect-
ing attention, vigilance, memory, psychomotor performance, and
executive function (Beebe et al., 2003; Aloia et al., 2004; Jackson
et al., 2011). However, the presence and the extent of the cognitive
changes in OSA subjects is still a matter of debate, the cogni-
tive impairment worsening with disease severity but not linearly
(Bedard et al., 1991; Boland et al., 2002). One study stresses that
although sleepiness and hypoxemia might cause the neuropsy-
chological deﬁcits in OSA patients, the co-morbidities usually
observed in these patients, i.e., cardiovascular diseases, obesity,
physical inactivity, are more important than sleep apnea per se in
affecting neurocognitive functions (Lim andVeasey, 2010). Finally,
we have to consider that there is a large heterogeneity in the neu-
ropsychological tests used in OSA patients making it difﬁcult to
compare the results (Décary et al., 2000).
Bearing in mind these limitations, in recent years special inter-
est has focused on impairments of executive function that refer to
the ability to develop and sustain an organized goal-directed and
ﬂexible approach to problem situations and to allow individuals to
use adaptively their basic skills in a complex and changing external
environment. This domain could be examined by tests demanding
working memory, mental ﬂexibility, planning, organization, and
problem solving (Fulda and Schulz, 2001; Saunamaki and Jehko-
nen, 2007), tasks related to prefrontal cortex activity (Beebe and
Gozal, 2002). Results of studies on cognitive function in OSA are
heterogeneous, some studies suggesting an executive dysfunction
(Bedard et al., 1991;Naëgele et al., 1995; Boland et al., 2002; Ferini-
Strambi et al., 2003; Lis et al., 2008; Torelli et al., 2011), and others
an attentional impairment (Redline et al., 1997; Lee et al., 1999;
Salorio et al., 2002;Verstraeten and Cludydts, 2004; Gosselin et al.,
2006; Yaouhi et al., 2009; Quan et al., 2011). The controversial
results may be partially explained by the severity of the disease, a
minor cognitive impairment present in mild cases (Redline et al.,
1997; Gosselin et al., 2006; Lis et al., 2008) and a greater deﬁcit
particularly in terms of executive function (Naëgele et al., 1995;
Ferini-Strambi et al., 2003; Aloia et al., 2004) in severe cases (AHI
circa 50).
In some studies supporting an executive dysfunction, perfor-
mance deﬁcits are not only reported in executive tests but in
all examined cognitive abilities, (Naëgele et al., 1995; Feuerstein
et al., 1997; Boland et al., 2002) suggesting a global cognitive
impairment. As suggested by Verstraeten and Cludydts (2004),
a methodological bias in the assessment of executive function
is the lack of control of attention performances during the task,
OSA patients showing a decline in the ability to sustain attention
(Dinges and Kribbs, 1991) and having alertness instability (Doran
et al., 2001). These two factors inﬂuence their performance. To
overcome this limitation, two studies (Naëgelé et al., 2006; Lis
et al., 2008) performed a combined evaluation of the executive
function and alertness, measuring both n-back task and reaction
time performances. Naëgelé et al. (2006) found that the untreated
OSAgroupdid not differ from the control groupondual tasks, e.g.,
combined auditory and visual digit span, that measure attentional
resources. In contrast, they differ in the maintenance and process-
ing components of workingmemory, suggesting thatOSA subjects
have difﬁculties in the processing of new information without
attention deﬁcit. In contrast, Lis and coworkers (Lis et al., 2008)
performing a combined evaluation of executive function (i.e.,
repeated working memory), and alertness (i.e., repeated reaction
time and subjective and objective sleepiness assessment), found a
decline in reaction time on all tasks and a lowered accuracy only
in the n-back test, suggesting a deﬁcit in attention and more basic
cognitive processes.
In terms of memory, studies in middle-aged patients (Salorio
et al., 2002; Naëgelé et al., 2006; Yaouhi et al., 2009) found a minor
impairment in word list learning and slightly decreased recall in
a visual episodic memory task. Naëgelé et al. (2006) observed a
free recall deﬁcit in episodic memory but normal maintenance
and recognition, conﬁrming that the memory impairment in OSA
is mild (Fulda and Schulz, 2001) and does not affect all memory
processes (Naëgele et al., 1995; Salorio et al., 2002; Naëgelé et al.,
2006).
EFFECTS OF TREATMENT
The current treatment of choice in OSA patients is the continuous
positive airway pressure (CPAP) inducing a signiﬁcant improve-
ment in daytime sleepiness (Engleman et al., 1996), a reduction
in occupational, work, and road accidents (Cassel et al., 1996) as
well as an improvement in general health (Reimer and Flemons,
1999; Sanner et al., 2000; Barbé et al., 2001; McFadyen et al., 2001).
When we consider the effect of CPAP on the cognitive function,we
can see that while some deﬁcits can be improved by therapy, other
domains such as executive function remain unchanged (Matthews
andAloia, 2011). To exclude the effect of an insufﬁcient treatment,
Weaver et al. (2007) examined patients before and after CPAP ther-
apy considering the objective adherence to treatment. They found
that, even among patients using CPAP for more than 7 h per night,
only 30% of these patients had a normalization of objective sleepi-
ness and only 50% had normal results on the Functional Outcome
of Sleep questionnaire. Zimmermann et al. (1996) studied ver-
bal memory changes in 58 memory-impaired OSA patients after 3
months of CPAP therapy. They found a dose-response relationship
between the level of CPAP adherence and the extent of improve-
ment in verbal memory with, however, a third of the patients with
6 h adherence not showing any improvement. Similar data were
reported byAntic et al. (2011) andLau et al. (2010) conﬁrming that
even the most optimally treated OSA patients may not experience
a complete reversal in attention and executive function, probably
due to a permanent brain alteration in severe cases (Bedard et al.,
1993; Naëgele et al., 1995; Feuerstein et al., 1997; Ferini-Strambi
et al., 2003).
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PATHOGENESIS OF COGNITIVE IMPAIRMENT
In large epidemiological studies (Kim et al., 1997; Boland et al.,
2002) analyzing memory and cognitive and psychomotor func-
tions, some authors found that OSA severity, as indicated by the
AHI, was signiﬁcantly related to diminished psychomotor efﬁ-
ciency with, however, a weak correlation. Similar ﬁndings were
described in the Danish MONICA study cohort comprising of
848 participants (Jennum and Sjol, 1994) in that an AHI> 5 was
associated with self-assessed concentration problems but not with
memory impairment. Today there is general agreement that not
apnea recurrence in itself, but the associated sleep fragmentation
and nocturnal hypoxemia, are the key factors affecting cogni-
tive function in patients with OSA (Bedard et al., 1991; Redline
et al., 1997; Engleman and Joffe, 1999; Daurat et al., 2008). This
hypothesis has been conﬁrmed by animal studies showing that
both intermittent hypoxia (Kalaria et al., 2004; Xu et al., 2004)
and sleep fragmentation (Tung et al., 2005; Nair et al., 2011), two
essential features of the OSA syndrome, can independently lead
to neuronal loss in the hippocampus and prefrontal cortex, areas
closely associated with memory processes and executive functions.
According to Beebe and Gozal (2002), the prefrontal cortex is
selectively susceptible to both sleep deprivation and hypoxemia.
The prefrontal cortex may exert modulatory inﬂuences on lower-
level processes sub-served by posterior cortical regions (Knight
et al., 1999) that have biological vulnerability to sleep loss and sleep
fragmentation (Horne,1993,1998;Thomas et al.,2000).Moreover,
attention control is believed to rely on the prefrontal cortex and its
interaction with the thalamus that we know is implicated in alert-
ness, vigilance and selective and sustained attention (Portas et al.,
1998; Jones andHarrison, 2001). If so, a combined deﬁcit in execu-
tive and attention skills is to be expected in OSA patients. It might
be suggested that at the beginning of the disease when patients
are asymptomatic or showing minimal cognitive impairment, a
chemical and dysfunctional brain injury could occur, reﬂected in
increased compensatory frontal activation during executive tasks.
During the progression of the disease, the chronic recurrence of
apneas and the progressive worsening of the hypoxemic stimulus
will induce structural brain lesions, explaining the greater cogni-
tive alteration, the impairment of executive tasks, and the lack of
cognitive normalization after treatment.
ROLE OF SLEEPINESS AND SLEEP FRAGMENTATION
Experimental reports (Dinges andKribbs,1991;Dinges et al., 1997;
McCoy and Strecher, 2011) in healthy subjects assumed that cog-
nition varies in parallel with changes in alertness, supporting the
hypothesis that sleepiness is the major factor underlying perfor-
mance impairment. However, when we consider OSA patients,
there is no linear relationship between the degree of sleepiness
and cognitive impairment, suggesting that in these patients cog-
nitive impairment is related more to an instability state (Doran
et al., 2001) acting on vigilance and attention than on execu-
tive dysfunction (Verstraeten and Cludydts, 2004). Moreover,OSA
patients without notable cognitive impairment have been found
in approximately half of a non-clinical population (Quan et al.,
2006) as well as in an elderly community population (Bixler et al.,
1998; Sforza et al., 2010), suggesting that there are some factors
protecting OSA patients from substantial cognitive deﬁcits (Beebe
et al., 2003). These factors include sleep deprivation tolerance (Mu
et al., 2005) and cognitive reserve that allow sleep-deprived sub-
jects (Drummond et al., 2005) or patients (Stern, 2002; Alchanatis
et al., 2005) to maintain intact performances. The hypothesis of a
reserve brain activation has been conﬁrmed by functional imaging
studies (fMRI) using cognitive tasks (Thomas et al., 2005; Ayalon
et al., 2006a, 2009a,b; Castronovo et al., 2009; Yaouhi et al., 2009;
Zhang et al., 2011) showing a decrease in frontal cortex metabo-
lism in the resting condition and an increase in neural activation
in frontal lobe, cingulate, thalamus, and hippocampus during task
activation.
ROLE OF HYPOXEMIA
From large population studies (Telakivi et al., 1988; Jennum and
Sjol, 1994;Kimet al., 1997;Redline et al., 1997;Horne,1998; Engle-
man and Joffe, 1999; Adams et al., 2001; Beebe and Gozal, 2002) it
would seem that, while the excessive daytime sleepiness and sleep
fragmentation inﬂuences attention, the hypoxemia contributes to
frontal impairment, and executive dysfunction. Using an experi-
mental model of OSA (Gozal et al., 2001) in rats exposed for 2
weeks to intermittent hypoxia, the authors found a neuronal loss
or apoptosis indicating a greater vulnerability of the frontal lobe
to hypoxemia. Moreover, Mc Coy et al. (2010) recently showed an
impaired allocation of attentional resources in rats exposed one
week to intermittent hypoxia. Since frontal lobes have dense con-
nections to other cortical areas (Fulda and Schulz, 2001; Beebe
and Gozal, 2002) the primary frontal dysfunction will progres-
sively affect other brain regions, inducing more complex cognitive
dysfunction. If so, the persistence of a neuropsychological deﬁcit
after CPAP (Bedard et al., 1993; Zimmermann et al., 1996; Lau
et al., 2010; Antic et al., 2011; Matthews and Aloia, 2011) may be
explained. However, if hypoxemia alone may explain the cognitive
dysfunction in severe cases, in mildly affected patients (Redline
et al., 1997; Lim and Veasey, 2010) the interacting effect of cogni-
tive reserve (McCoy and Strecher, 2011), intelligence level (Quan
et al., 2006), and depression (Sachs-Ericsson et al., 2005; Cross
et al., 2008) needs to be considered.
NEUROIMAGING DATA
Within the past decade, the growing prevalence of functional
neuroimaging studies has induced an increased interest in the
association between OSA and cognition and has opened a new
window on the role of cerebral metabolic and circulatory impair-
ment in neuropsychological dysfunction. Routine neuroimaging
studies (MRI) in OSA patients have reported inconsistent ﬁnd-
ings (Davies et al., 2001) or silent vascular lesions (O’Donoghue
et al., 2005; Nishibayashi et al., 2008) suggesting a general brain
impairment. Voxel-based morphometry (Macey et al., 2002, 2008)
have demonstrated a gray matter reduction in brain regions that
regulate memory and executive functions, i.e., cingulum, frontal,
parietal and temporal areas, and hippocampus. More sensitive
techniques (Zimmermann and Aloia, 2006) such as spectroscopy
(Kamba et al., 1997; O’Donoghue et al., 2012), functional MRI
(Canessa et al., 2011), or positron emission tomography (PET;
Morrell et al., 2003) have revealed functional alterations in spe-
ciﬁc brain areas implicated in cognitive function and affecting the
prefrontal and the parieto-occipital cortex (Yaouhi et al., 2009) and
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the hippocampus (Torelli et al., 2011), the latter critical for mem-
ory. Interestingly, in the Yaouhi et al. (2009) study, the authors
found that gray matter density and metabolic levels were altered
even in patients without cognitive disturbances, suggesting that
cerebral changes precede the onset of neuropsychological deﬁcits.
Canessa et al. (2011) performed a neuropsychological testing and
voxel-based morphometry in 17 severely affected patients before
and after 3-months of CPAP treatment. Prior to treatment the
patients had poorer performances in some cognitive tests and a
reduction of gray matter volume in the hippocampus, parietal cor-
tex and frontal areas. After treatment there was an improvement
in memory, attention and executive functions that paralleled the
gray matter increase in the hippocampus and frontal areas, with-
out, however, a complete normalization both in cognitive function
and gray matter density. In contrast, a recent study using magnetic
resonance spectroscopy (O’Donoghue et al., 2012) shows thatOSA
patients had decreased metabolic activity in the frontal lobe and
hippocampus that did not correlate with cognitive scores and did
not change after 6 months of CPAP therapy.
To date, any signiﬁcant relationship between cognitive scores
and brain morphological alteration has been reported, except for
a slight association between hippocampal gray matter decrease,
and memory dysfunction (Yaouhi et al., 2009) and the gray mat-
ter increase in the left entorhinal cortex in patients showing a
reduction of errors at the Stroop test (Canessa et al., 2011). The
lack of signiﬁcant relationship between morphological changes
and neuropsychological scores may be explained by the interplay
of compensatory mechanisms reﬂected by the increased activa-
tion of frontal areas and hippocampus in fMRI and PET studies
(Castronovo et al., 2009; Yaouhi et al., 2009).
COGNITIVE FUNCTION IN ELDERLY OSA SUBJECTS
Although several studies have shown that the prevalence of OSA
increases with age (Bixler et al., 1998, 2001; Young et al., 2002)
there is debate as to whether OSA phenotype in older adults is
equal to that in middle-aged patients (Ancoli-Israel et al., 1991;
Phillips et al., 1992; Bliwise, 1994; Young, 1996) and whether the
aging per se increases the susceptibility to cognitive dysfunction
(Alchanatis et al., 2008; Mathieu et al., 2008). A ﬁrst epidemiolog-
ical survey (Boland et al., 2002) has not revealed any evidence of
a dose-response relationship between the respiratory disturbance
index and cognitive function score in a cohort of 837 men and
923 women over 60 years old. Studies performed on sleep clinic
patients have given conﬂicting results, some authors reporting a
relationship between cognitive impairment and OSA (Kim et al.,
1997; Cohen-Zion et al., 2001) in older patients, while others do
not (Phillips et al., 1992). Severity of the disease seems to play a key
role in cognitive deﬁcit, older patients being more likely to have
a cognitive deﬁcit in attention and executive function when the
AHI is greater than 30 (Aloia et al., 2004). In a prospective study
conducted on 289 women aged 82 with mild cognitive impair-
ment and dementia (Yaffe et al., 2011) the authors demonstrated
that older OSA women had an increased risk of developing mild
cognitive impairment or dementia after 5 years, stressing the key
role of OSA in the increased cognitive risk. When treated, patients
without (Aloia et al., 2003) or with mild dementia (Ancoli-Israel
andCoy,1994;Ayalon et al.,2006b;Ancoli-Israel et al.,2008;Cooke
et al., 2009) have a slower cognitive deterioration and sometimes
even an improvement thus stressing the link between cognitive
decline and OSA.
To explain the link between cognitive decline and OSA in the
elderly, an emerging hypothesis is that the chronic intermittent
hypoxemia observed in OSA patients might be seen as a factor
which expedites the effects of other conditions, particularly aging,
that are known to cause brain atrophy or damage in the prefrontal
cortex and hippocampus. Ayalon et al. (2010) demonstrate that
the presence of OSA accelerates the age-related decline in cogni-
tive performances in middle-aged patients (>45 years) showing a
decreased activation of the frontal gyrus, hippocampus, and pari-
etal lobe during a sustained attention and a verbal encoding task.
These results are supported by amorphological study (Torelli et al.,
2011) showing a correlation between age and volumes of the total
and left hippocampus, amygdale, and brain parenchyma in OSA
patients. If the presence of OSA can be seen as a factor which
accelerates the process of brain aging, an early treatment should
be proposed (Pack and Maislin, 2001; Ancoli-Israel, 2007) to pre-
vent or to slow the cognitive deterioration (Cohen-Zion et al.,
2001).
In summary, the connection between OSA and cognition, the
increase of OSA risk in general population and the increasing
aging population underline the need of further studies on the risk
of development of a cognitive impairment in OSA patients and
on the long-term effect of therapy on the age-related cognitive
decline.
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